Recent news and media coverage for Ampa
Ampa One is FDA-cleared for the treatment of treatment-resistant depression in adults. Some of the content on this page describes uses, patient populations, or treatment parameters outside Ampa One's FDA-cleared indication. Ampa One has not been cleared or approved by FDA for those uses, and its safety and effectiveness for those uses have not been established. These publications are provided for scientific reference and are not intended to promote use of Ampa One outside its FDA-cleared indication.